Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2018-07-31 2018-05-04
Drug Identification Number 02385961 02385961
Brand name RANITIDINE RANITIDINE
Common or Proper name RANITIDINE RANITIDINE
Company Name SIVEM PHARMACEUTICALS ULC SIVEM PHARMACEUTICALS ULC
Ingredients RANITIDINE RANITIDINE
Strength(s) 300MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-05-14 2018-05-14
Actual start date 2018-04-27 2018-04-27
Estimated end date Unknown
Actual end date 2018-07-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Temporarily unavailable
Health Canada comments